Skip to main content
. 2022 Aug 5;10(8):1574. doi: 10.3390/microorganisms10081574

Figure 7.

Figure 7

Figure 7

Microbiota content of patients with MS before and after IC by qPCR. Escherichia coli (a), Enterobacter spp. (b), Bacteroides fragilis (c) and Bifidobacterium spp. (d). Notes: HV—healthy volunteers; MS—patients with metabolic syndrome; MS+IC—patients with metabolic syndrome after consumption of indigenous consortium. Results are presented as median (25%; 75%).